First Patient Infused in Joint Humanigen/Kite, A Gilead Company Clinical Study

Humanigen, Inc., a clinical stage biopharmaceutical company focused on preventing and treating cytokine release syndrome with lenzilumab, the company’s proprietary Humaneered® anti-human granulocyte macrophage-colony stimulating factor monoclonal antibody, announced that the first patient has been infused in the ZUMA-19 study, which is being conducted in collaboration with Kite, A Gilead […]

Can-Fite Announces Final Data Analysis from Phase II NASH Study: Highly Significant and Sustained Reduction in Liver Fat Volume Throughout Study Period

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced that the final data analysis from its Phase II study of Namodenoson in the treatment of patients with non-alcoholic fatty liver disease with or without non-alcoholic steatohepatitis has […]

Altimmune Announces Dosing of First Patient in Phase 1b Clinical Trial of NasoShield™, a Single Dose Intranasal Anthrax Vaccine Candidate

Altimmune, Inc., a clinical-stage biopharmaceutical company, announced dosing of the first patient in the Company’s Phase 1b clinical trial of NasoShield, a single dose intranasal anthrax vaccine candidate. Go to Source Start Free Trial: Database Active Pharma Ingredients Manufacturers – API Database contains 43 000 generic API listed with price ranges. […]

Obesity linked to higher risk of dementia

UCL researchers find a 31% increased risk of dementia in those with high BMI Go to Source Start Free Trial: Database Active Pharma Ingredients Manufacturers – API Database contains 43 000 generic API listed with price ranges. Including regulatory information, price ranges US market, EU, Canada, and other regulated markets and […]

EC clears new class of anaemia therapy

BMS’ Reblozyl is the first and only erythroid maturation agent approved in the EU Go to Source Start Free Trial: Database Active Pharma Ingredients Manufacturers – API Database contains 43 000 generic API listed with price ranges. Including regulatory information, price ranges US market, EU, Canada, and other regulated markets and […]

Eight medicines leap towards EU approval

The recommendations include a conditional approval for Gilead’s Veklury (remdesivir) for COVID-19 Go to Source Start Free Trial: Database Active Pharma Ingredients Manufacturers – API Database contains 43 000 generic API listed with price ranges. Including regulatory information, price ranges US market, EU, Canada, and other regulated markets and rest of […]

Intercept’s NASH drug faces its biggest delay yet

The FDA rejected obeticholic acid, asking for more data. If the agency ends up requiring outcomes results too, it could set Intercept’s approval hopes back by two years or more. Go to Source Start Free Trial: Database API Sourcing – API Database contains 43 000 generic API listed with price ranges. Including regulatory […]